Old Web
English
Sign In
Acemap
>
authorDetail
>
Luyang Yao
Luyang Yao
University of Texas MD Anderson Cancer Center
Medicine
Internal medicine
Oncology
Lung cancer
locally advanced
4
Papers
104
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
I-SABR phase II randomized study of nivolumab immunotherapy and stereotactic ablative radiotherapy in early stage NSCLC: Interim analysis adverse effects.
2020
Journal of Clinical Oncology
Joe Y. Chang
Steven H. Lin
Luyang Yao
S. Gandhi
Zhongxing X. Liao
Stephen G. Chun
Melenda Jeter
James Welsh
Percy Lee
Mara B. Antonoff
Lei Feng
J. Jack Lee
John V. Heymach
Show All
Source
Cite
Save
Citations (3)
A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction.
2020
Journal of Clinical Oncology
Everett J. Moding
Mohammad Shahrokh Esfahani
Barzin Y. Nabet
Yufei Liu
Jacob J. Chabon
Jianzhong He
Yawei Qiao
Ting Xu
Luyang Yao
S. Gandhi
Zhongxing X. Liao
Millie Das
Kavitha Ramchandran
Sukhmani K. Padda
Joel W. Neal
Heather A. Wakelee
Billy W. Loo
Steven H. Lin
Ash A. Alizadeh
Maximilian Diehn
Show All
Source
Cite
Save
Citations (1)
1